Sign In
Buy PTC
$139.72
-2.62 (-1.84%)
At Close: Jun 03, 2026
PTC Therapeutics to Participate at Upcoming Investor Conferences
04:30pm, Wednesday, 28'th Aug 2024
WARREN, N.J. , Aug. 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences: Morgan Stanley 22nd A
PTC Will Participate in Upcoming Investor Conferences
08:00am, Tuesday, 27'th Aug 2024
BOSTON , Aug. 27, 2024 /PRNewswire/ -- PTC (Nasdaq: PTC) today announced that it will participate in the following conferences. What: Citi's 2024 Global TMT Conference When: Wednesday, September 4th
Get Your Money Out of These 3 Robotics Stocks by 2025
08:55am, Thursday, 15'th Aug 2024
Robotics continues to pique investors' interest, and even more so as we enter a new age of artificial intelligence technologies. Automation has been a significant catalyst for the space.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
10:00am, Sunday, 11'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised
1 Magnificent Software Stock Down 10% to Buy and Hold Forever
05:05am, Sunday, 11'th Aug 2024
The annual run rate of recurring revenue continues to grow at a double-digit rate. Free cash flow is growing more than recurring revenue growth.
The 3 Best Augmented Reality Stocks to Buy in August 2024
08:00am, Saturday, 10'th Aug 2024
As we advance further into the digital age, augmented reality (AR) continues to emerge as a pivotal technology reshaping numerous industries. The AR market is ripe for significant growth.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
10:30am, Friday, 09'th Aug 2024
NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
04:01pm, Thursday, 08'th Aug 2024
– Continued strong revenue performance – – NDAs for sepiapterin and Translarna™ submitted to FDA – – Positive interim data readout from PTC518 PIVOT-HD study – – On track to achieve re
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
03:50pm, Wednesday, 07'th Aug 2024
NEW YORK, NY / ACCESSWIRE / August 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ:PTCT). Such investors are advised t
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
03:41pm, Saturday, 03'rd Aug 2024
NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are
PTC Inc. (PTC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
07:01pm, Friday, 02'nd Aug 2024
While the top- and bottom-line numbers for PTC Inc. (PTC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
06:44pm, Thursday, 01'st Aug 2024
NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. ("PTC" or the "Company") (NASDAQ: PTCT). Such investors are advised to
PTC's Q3 Earnings Match Estimates, Revenues Decrease Y/Y
11:10am, Thursday, 01'st Aug 2024
PTC Inc. PTC reported third-quarter fiscal 2024 non-GAAP earnings per share (EPS) of 98 cents, down 1% on a year-over-year basis. The figure came in line with the Zacks Consensus Estimate.
PTC Inc. (PTC) Q3 2024 Earnings Call Transcript
11:24pm, Wednesday, 31'st Jul 2024
PTC Inc. (NASDAQ:PTC ) Q3 2024 Results Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - Chief Executive Officer Kristian Tal
PTC Inc. (PTC) Q3 Earnings Meet Estimates
06:11pm, Wednesday, 31'st Jul 2024
PTC Inc. (PTC) came out with quarterly earnings of $0.98 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.99 per share a year ago.
